During the past decade, University of California, Irvine, Institute for Brain Aging and Dementia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California, Irvine, Institute for Brain Aging and Dementia" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "National Institute on Aging (NIA)" with 3 trials sponsored, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials sponsored, "Biogen" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California, Irvine, Institute for Brain Aging and Dementia" #1 collaborator was "Alzheimer's Disease Cooperative Study (ADCS)" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of California, Irvine, Institute for Brain Aging and Dementia" are "Alzheimer's Disease" (4 trials), "Alzheimer Disease" (3 trials), "Cognition Disorders" (1 trials), "Dyssomnias" (1 trials) and "Early Preclinical Alzheimer's Disease" (1 trials). Many other conditions were trialed in "University of California, Irvine, Institute for Brain Aging and Dementia" in a lesser frequency.

Most popular intervention types in "University of California, Irvine, Institute for Brain Aging and Dementia" are "Drug" (8 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Solanezumab" (2 trials), "Aducanumab" (1 trials), "Donanemab" (1 trials) and "Folate" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of California, Irvine, Institute for Brain Aging and Dementia" are 9 trials for "All" genders.

Currently, there are NaN active trials in "University of California, Irvine, Institute for Brain Aging and Dementia". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of California, Irvine, Institute for Brain Aging and Dementia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of California, Irvine, Institute for Brain Aging and Dementia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".